118 related articles for article (PubMed ID: 24256053)
1. Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Yang P; Liang SX; Huang WH; Zhang HW; Li XL; Xie LH; Du CW; Zhang GJ
Curr Mol Med; 2014 Jan; 14(1):174-84. PubMed ID: 24256053
[TBL] [Abstract][Full Text] [Related]
2. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
3. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
4. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
5. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer.
Chen HW; Du CW; Wei XL; Khoo US; Zhang GJ
Curr Mol Med; 2013 Mar; 13(3):410-6. PubMed ID: 23331013
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
8. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract][Full Text] [Related]
9. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization.
Kallergi G; Tsintari V; Sfakianakis S; Bei E; Lagoudaki E; Koutsopoulos A; Zacharopoulou N; Alkahtani S; Alarifi S; Stournaras C; Zervakis M; Georgoulias V
Breast Cancer Res; 2019 Aug; 21(1):86. PubMed ID: 31370904
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
Chen HY; Clayman ES; Ma WF
J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
15. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.
Kalpana G; Figy C; Yeung M; Yeung KC
Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4.
Alevizos L; Kataki A; Derventzi A; Gomatos I; Loutraris C; Gloustianou G; Manouras A; Konstadoulakis MM; Zografos G
Clin Exp Metastasis; 2014 Jun; 31(5):511-20. PubMed ID: 24590865
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
18. Silencing of CXCR4 blocks breast cancer metastasis.
Liang Z; Yoon Y; Votaw J; Goodman MM; Williams L; Shim H
Cancer Res; 2005 Feb; 65(3):967-71. PubMed ID: 15705897
[TBL] [Abstract][Full Text] [Related]
19. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
[TBL] [Abstract][Full Text] [Related]
20. Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition.
Lee H; Ko JH; Baek SH; Nam D; Lee SG; Lee J; Yang WM; Um JY; Kim SH; Shim BS; Ahn KS
Phytother Res; 2016 Jun; 30(6):1021-32. PubMed ID: 27030214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
